Grever MR - Search Results

1

A pharmacokinetic/pharmacodynamic model of tumor lysis syndrome in chronic lymphocytic leukemia patients treated with flavopiridol.

Ji J, Mould DR, Blum KA, Ruppert AS, Poi M, Zhao Y, Johnson AJ, Byrd JC, Grever MR, Phelps MA. Ji J, et al. Among authors: grever mr. Clin Cancer Res. 2013 Mar 1;19(5):1269-80. doi: 10.1158/1078-0432.CCR-12-1092. Epub 2013 Jan 8. Clin Cancer Res. 2013. PMID: 23300276 Free PMC article. Clinical Trial.

2

Fludarabine monophosphate: a potentially useful agent in chronic lymphocytic leukemia.

Grever MR, Kopecky KJ, Coltman CA, Files JC, Greenberg BR, Hutton JJ, Talley R, Von Hoff DD, Balcerzak SP. Grever MR, et al. Nouv Rev Fr Hematol (1978). 1988;30(5-6):457-9. Nouv Rev Fr Hematol (1978). 1988. PMID: 2464793

3

Introduction: chronic lymphocytic leukemia.

Byrd JC, Flinn IW, Grever MR. Byrd JC, et al. Among authors: grever mr. Semin Oncol. 1998 Feb;25(1):4-5. Semin Oncol. 1998. PMID: 9482520 No abstract available.

4

Old and new therapies in chronic lymphocytic leukemia: now is the time for a reassessment of therapeutic goals.

Byrd JC, Rai KR, Sausville EA, Grever MR. Byrd JC, et al. Among authors: grever mr. Semin Oncol. 1998 Feb;25(1):65-74. Semin Oncol. 1998. PMID: 9482528 Review.

5

Herpes zoster and lymphopenia associated with sodium stibogluconate therapy for cutaneous leishmaniasis.

Wortmann GW, Aronson NE, Byrd JC, Grever MR, Oster CN. Wortmann GW, et al. Among authors: grever mr. Clin Infect Dis. 1998 Sep;27(3):509-12. doi: 10.1086/514689. Clin Infect Dis. 1998. PMID: 9770149 Clinical Trial.

6

Flavopiridol induces apoptosis in chronic lymphocytic leukemia cells via activation of caspase-3 without evidence of bcl-2 modulation or dependence on functional p53.

Byrd JC, Shinn C, Waselenko JK, Fuchs EJ, Lehman TA, Nguyen PL, Flinn IW, Diehl LF, Sausville E, Grever MR. Byrd JC, et al. Among authors: grever mr. Blood. 1998 Nov 15;92(10):3804-16. Blood. 1998. PMID: 9808574 Free article.

7

Flavopiridol (L86-8275): selective antitumor activity in vitro and activity in vivo for prostate carcinoma cells.

Drees M, Dengler WA, Roth T, Labonte H, Mayo J, Malspeis L, Grever M, Sausville EA, Fiebig HH. Drees M, et al. Clin Cancer Res. 1997 Feb;3(2):273-9. Clin Cancer Res. 1997. PMID: 9815683

8

Minimal residual disease in patients with hairy cell leukemia in complete remission treated with 2-chlorodeoxyadenosine or 2-deoxycoformycin and prediction of early relapse.

Tallman MS, Hakimian D, Kopecky KJ, Wheaton S, Wollins E, Foucar K, Cassileth PA, Habermann T, Grever M, Rowe JM, Peterson LC. Tallman MS, et al. Clin Cancer Res. 1999 Jul;5(7):1665-70. Clin Cancer Res. 1999. PMID: 10430066

9

Depsipeptide (FR901228): a novel therapeutic agent with selective, in vitro activity against human B-cell chronic lymphocytic leukemia cells.

Byrd JC, Shinn C, Ravi R, Willis CR, Waselenko JK, Flinn IW, Dawson NA, Grever MR. Byrd JC, et al. Among authors: grever mr. Blood. 1999 Aug 15;94(4):1401-8. Blood. 1999. PMID: 10438728 Free article.

10

Theophylline, pentostatin (Nipent), and chlorambucil: a dose-escalation study targeting intrinsic biologic resistance mechanisms in patients with relapsed lymphoproliferative disorders.

Byrd JC, Grever MR, Waselenko JK, Willis CR, Park K, Goodrich A, Lucas MA, Shinn C, Flinn IW. Byrd JC, et al. Among authors: grever mr. Semin Oncol. 2000 Apr;27(2 Suppl 5):37-40. Semin Oncol. 2000. PMID: 10877050

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

323 results

Search Page

Filters